Skip to content
Menu

Amrize Lowers FY2026 Sales Guidance from $12.500B-$12.700B to $12.200B-$12.400B vs $12.540B Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Amrize (NYSE:AMRZ) lowers FY2026 sales outlook from $12.500 billion-$12.700 billion to $12.200 billion-$12.400 billion vs $12.540 billion estimate.

Amrize (NYSE:AMRZ) lowers FY2026 sales outlook from $12.500 billion-$12.700 billion to $12.200 billion-$12.400 billion vs $12.540 billion estimate.

Read at benzinga.com